LATEST NEWS

The new Reina Lab aims to charge up killer T cells against tumors
Scientists find evidence that all cancer patients mount an immune response to their tumors, suggesting that many more patients could benefit from personalized immunotherapy
T cells have the amazing ability to differentiate into many subtypes of T cells, all with different jobs in the
By tracking T cell activity, researchers uncover promising tuberculosis vaccine and drug targets
LJI Professor Emeritus Toshiaki Kawakami, M.D., Ph.D., uncovered the molecular underpinnings of allergy, tumor responses, and more
In this seminar, Dr. Andrea L. Cox, M.D., Ph.D., shares her research into “Immunologic and Metabolic Profiling of the Response
New LJI research demonstrates the importance of harnessing "cross-reactive" T cells to combat SARS-CoV-2
LJI researchers uncover special T cell subset that helps fight cytomegalovirus infection
New research suggests a small group of pediatric brain tumor patients may benefit from immunotherapy
LJI scientists harness bioinformatics to predict how T cells may adapt to fighting the highly mutated Pirola variant
Researchers map the genome to figure out how a protein called IKAROS controls healthy B cell development
Local student Maya Krishnan hopes to improve biosafety for healthcare workers. LJI's Laurence Cagnon shares her expertise and mentorship.